亚太药业：2025年半年度净利润约1.05亿元，同比增加1820.97%

Company Performance - Asia-Pacific Pharmaceutical reported a revenue of approximately 152 million yuan for the first half of 2025, representing a year-on-year decrease of 31.48% [1] - The net profit attributable to shareholders of the listed company was approximately 105 million yuan, showing a significant year-on-year increase of 1820.97% [1] - Basic earnings per share increased to 0.14 yuan, reflecting a year-on-year growth of 1300% [1] Industry Context - The domestic market is witnessing the first A-level car exhibition in the second half of the year, with nearly 120 brands and 1600 vehicles participating, indicating a competitive landscape in the automotive sector [1]